Gerald Pohost
Cardiovascular Disease · Glendale, CANPI 1871534636
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 43 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $464 and has fallen 94.5% since, to $26 in 2025. That places this record below the midpoint for cardiovascular disease clinicians in CA, where the typical reported total is $2,142.
Across 43 payments — averaging $27.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$175
- Novartis$125
- AbbVie$119
- Pfizer$113
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$93
- Abbott$74
- plus $463 from 16 others
What the payments were for
- Food & beverage$1,164100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 9 | $175 |
| Novartis | 1 | $125 |
| AbbVie(2 entities) | 6 | $119 |
| Pfizer | 1 | $113 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $93 |
| Abbott | 1 | $74 |
| Siemens Medical Solutions USA, Inc. | 1 | $73 |
| Novo Nordisk | 2 | $45 |
| Kestra Medical Technology Services, Inc. | 2 | $39 |
| Amgen | 2 | $38 |
| Kowa Pharmaceuticals America, Inc. | 2 | $36 |
| Currax Pharmaceuticals LLC | 2 | $35 |
| Boston Scientific | 1 | $31 |
| Bayer | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Arbor Pharmaceuticals, Inc. | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
| Medtronic | 1 | $18 |
| Merck | 1 | $17 |
| Tactile Systems Technology Inc | 1 | $15 |
| Itamar Medical Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENTRESTO$125
How this compares
$1,164 in reported general payments places this provider in the 40th percentile of 2,184 cardiovascular disease providers in California.
Other cardiovascular disease in Glendale
- Ted LoveHillsborough$102.8M
- Paul KurthSanta Barbara$6.1M
- Jason RogersSacramento$4.4M
- Matthew BudoffTorrance$3.6M
- Eric Topolla Jolla$2.2M
- Cathleen Bairey-MerzLos Angeles$1.2M
- Gagan SinghSacramento$1.2M
- Pam Taubla Jolla$1.2M
- Wilber SuStanford$1.1M
- Thomas SmithSacramento$942K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.